Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonidas E Bantis

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Cancer Research Communications|July 21, 2025
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular VesiclesJared Sipes, Didi Zha, Sagar Rayamajhi, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
Journal of the National Cancer Institute|April 5, 2017
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic CancerMichela Capello, Leonidas E Bantis, Ghislaine Scelo, et al.
Nature Communications|January 18, 2019
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicityMichela Capello, Jody V Vykoukal, Hiroyuki Katayama, et al.
JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
JAMA Oncology|July 14, 2018
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins, Florence Guida, Nan Sun, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Cancer Research Communications|July 21, 2025
Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular VesiclesJared Sipes, Didi Zha, Sagar Rayamajhi, et al.
Journal of the National Cancer Institute|August 24, 2018
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic CancerJohannes F Fahrmann, Leonidas E Bantis, Michela Capello, et al.
Journal of the National Cancer Institute|April 5, 2017
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic CancerMichela Capello, Leonidas E Bantis, Ghislaine Scelo, et al.
Nature Communications|January 18, 2019
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicityMichela Capello, Jody V Vykoukal, Hiroyuki Katayama, et al.
JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.
JCO Precision Oncology|January 20, 2022
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 DiabetesMichela Capello, Johannes F Fahrmann, Mayrim V Rios Perez, et al.
JAMA Oncology|July 14, 2018
Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins, Florence Guida, Nan Sun, et al.
Pageof 5